Sudden Cardiac Death Following Use of the Synthetic Cannabinoid MDMB-CHMICA.
Department of Clinical Pharmacology, St. Olav University Hospital, Trondheim, Norway.
Andreas Austgulen
AA
Westin
Department of Clinical Pharmacology, St. Olav University Hospital, Trondheim, Norway.
Joachim
J
Frost
Department of Clinical Pharmacology, St. Olav University Hospital, Trondheim, Norway.
Wenche Rødseth
WR
Brede
Department of Clinical Pharmacology, St. Olav University Hospital, Trondheim, Norway.
Per Ole M
PO
Gundersen
Department of Emergency Medicine, St. Olav University Hospital, Trondheim, Norway.
Steinar
S
Einvik
Department of Pathology and Medical Genetics, St. Olav University Hospital, Trondheim, Norway.
Harald
H
Aarset
Department of Clinical Pharmacology, St. Olav University Hospital, Trondheim, Norway Department of Laboratory Medicine, Children's and Women's Health, Norwegian University of Science and Technology, Trondheim, Norway lars.slordal@ntnu.no.
Lars
L
Slørdal
D000328:Adult; D002186:Cannabinoids / Q000008:administration & dosage / Q000097:blood* / Q000506:poisoning*; D002853:Chromatography, Liquid; D016757:Death, Sudden, Cardiac / Q000209:etiology*; D017809:Fatal Outcome; D006801:Humans; D007211:Indoles / Q000008:administration & dosage / Q000097:blood / Q000506:poisoning*; D008297:Male; D013154:Spleen / Q000737:chemistry / Q000473:pathology; D053719:Tandem Mass Spectrometry; D055815:Young Adult
D002186:Cannabinoids; D007211:Indoles; C000610109:methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate